Patents by Inventor Jakob Hraschan

Jakob Hraschan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190329265
    Abstract: The invention provides a method for the production of a zeolite particle composition which has optimized characteristics, such as enhanced adsorption and specific ion exchange properties. A method and an apparatus for producing improved zeolite particle compositions are provided, where the particles are treated with an oxygen-containing gas during micronisation. The zeolite particle compositions can be used in a method for treatment of the human or animal body by therapy and/or prophylaxis, and specifically in a method of treating or preventing conditions of the human or animal body or symptoms of these conditions that are related to heavy metals, endotoxins, exotoxins, and/or bacterial, viral or parasitic intoxications in or of the digestive system, mucosal surfaces or the skin. Also, new zeolite particle compositions can be used as food additive, as filter for purification of water, in packaging materials, or as cosmetic ingredient.
    Type: Application
    Filed: December 1, 2017
    Publication date: October 31, 2019
    Inventor: Jakob Hraschan
  • Patent number: 9415064
    Abstract: Prevention or treatment of painful polyneuropathies caused by toxic agents, i.e. to the prevention, reduction or elimination of the symptoms associated with such polyneuropathies, such as neuropathic pain are disclosed. An aluminosilicate for use in such prevention or treatment, preferably a natural or synthetic zeolite, such as clinoptilolite, is provided. The toxic agent is, in particular, a chemotherapeutic cytotoxic agent.
    Type: Grant
    Filed: December 4, 2012
    Date of Patent: August 16, 2016
    Inventor: Jakob Hraschan
  • Publication number: 20140057000
    Abstract: The invention relates to the prevention or treatment of painful polyneuropathies caused by toxic agents, i.e. to the prevention, reduction or elimination of the symptoms associated with such polyneuropathies, such as neuropathic pain. The invention provides an aluminosilicate for use in such prevention or treatment, preferably a natural or synthetic zeolite, such as clinoptilolite. The toxic agent is, in particular, a chemotherapeutic cytotoxic agent.
    Type: Application
    Filed: December 4, 2012
    Publication date: February 27, 2014
    Inventor: Jakob Hraschan
  • Publication number: 20060292242
    Abstract: The invention relates to lowering the lactate values or the ammonium values in the blood of mammals, including humans. According to the invention, ground zeolites are administered orally in the form of a consumption product or a drug. In particular, the zeolite is chosen from the group of natural zeolites such as clinoptilolite, silver zeolite, mordenite, phillipsite, and analcite, and/or from the group of synthetic zeolites such as zeolite A, zeolite W, and zeolite X.
    Type: Application
    Filed: February 26, 2003
    Publication date: December 28, 2006
    Inventors: Jakob Hraschan, Christian Herzog, Antonio Lelas